prevention of hepatitis b recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis b immunoglobulin
نویسندگان
چکیده
منابع مشابه
Prevention of Hepatitis B Recurrence in Liver Transplant Patients Using Oral Antiviral Therapy without Long-Term Hepatitis B Immunoglobulin
BACKGROUND Small studies have suggested that nucleos(t)ide analogue therapy (NAT) with reduced hepatitis B immunoglobulin (HBIG) duration may be efficacious in preventing post-liver transplantation (LT) HBV recurrence. OBJECTIVES This larger study evaluates the use of NAT with short term (< 6 mo) or no HBIG for prevention of post-LT HBV recurrence. PATIENTS AND METHODS All HBV patients unde...
متن کاملSurface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy
Objective (s):The aim of this study was to determine the correlation between vaccine therapy and appearance of mutations in hepatitis B surface antigen (HBsAg)-positive chronic hepatitis B virus (HBV) patients. Materials and Methods: 16 patients received the HBV vaccine and another 16 individuals from the control group did not. The surface gene was amplified and directly sequenced from samples...
متن کاملEvolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B.
BACKGROUND Long-term lamivudine (LAM), adefovir (ADV) and entecavir (ETV) treatment induce the emergence of drug-resistant hepatitis B virus (HBV) in patients with chronic hepatitis B infection. AIM To evaluate the LAM, ADV and ETV resistance mutations detected in our patient group. MATERIALS AND METHODS Twenty patients who had received at least two years of treatment with nucleoside/tide a...
متن کاملHepatitis B Prevention and Immunization
هپاتیت به معنی التهاب کبد است. هپاتیت B هپاتیت سرمی هم نامیده می شود، ویروس آن از خون، مایعات سروزی بدن، بزاق و مایع منی یافت شده و باعث می گردد که سلولهای کبدی به دنبال واکنش التهابی عملکرد خود را از دست دهند که این حالت ممکن است منجر به انسداد مجاری صفراوی و یا نارسایی کبد شود.
متن کاملSide effects of long-term oral antiviral therapy for hepatitis B.
The aim of this review is to summarize the safety profile of the five approved oral nucleoside analogs used to treat chronic hepatitis B virus (HBV) infection, focusing on both the class adverse effects and those that have been reported with individual agents, as well as their safety in pregnancy. All nucleoside analogs have a "Black Box" warning because of their potential for inhibition of hum...
متن کاملPrevention of hepatitis B virus reinfection in liver transplant recipients.
Antiviral therapy using newer nucleos(t)ide analogues with lower resistance rates such as entecavir or tenofovir could suppress hepatitis B virus (HBV) replication, improve liver function, delay or obviate the need for liver transplantation in some patients, and reduce the risk of HBV recurrence. The combination of long-term antiviral and low-dose hepatitis B immune globulin (HBIG) can effectiv...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
hepatitis monthlyجلد ۱۱، شماره ۸، صفحات ۶۳۸-۶۴۵
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023